ECHA

A series of IT maintenance activities kicking off

We are kicking off a series of IT maintenance activities starting in September 2024. This will affect the availability of our IT tools and websites. We will mainly carry out the work over certain weekends, between Friday evening and Monday noon.

The first break will start on Friday 20 September 2024 at 18:00 (Helsinki time) and affect the following tools:

• REACH-IT - exception: unavailable already from 12:00;
• ePIC; and
• Webforms (including consultation and contact forms).

All tools are available again on Monday 23 September 2024 at 12:00.

Follow our IT maintenance web page for latest updates.

CLP

RAC opinions on harmonising the classification and labelling of three lithiums salts and MMA

Opinions of our Risk Assessment Committee (RAC) on lithium carbonate, lithium chloride and lithium hydroxide, and methyl methacrylate (MMA) are now available on our website. These opinions were developed in response to a request from the European Commission to review an earlier opinion.
 
The Commission considers RAC opinions when deciding whether to include and update the harmonised classification and labelling of these substances in Annex VI to the CLP Regulation. The Annex lists all hazardous substances with harmonised classification and labelling.

New intention and proposal to harmonise classification and labelling

One intention has been submitted for:

• Reaction products of boric acid with 2-propylheptan-1-ol (1:3) [1] 2,2'-methyliminodiethanol and its reaction products with boric acid (1:1.5) [2] (EC -, CAS -).

One proposal has been submitted for:

• brodifacoum (ISO); 4-hydroxy-3-(3-(4′-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin (EC 259-980-5, CAS 56073-10-0).
  

Court judgments

Court confirms ECHA's and Board of Appeal's position related to compliance check decision and cease of manufacture

The General Court dismisses actions against:

• ECHA's Board of Appeal’s decision in case A-009-2020; and
• a letter that ECHA sent to Italian competent authorities in February 2022

concerning the follow-up of a compliance check decision.

In its judgments, the Court confirmed ECHA's view that a registrant that ceases to manufacture or import a substance after the adoption of a compliance check decision is not relieved of its obligation to provide the information requested in that decision.

Read more about Case T-29/22 and Case T-192/22.

Others

New tool to identify carcinogens at work

The renewed Roadmap on Carcinogens website provides more practical help and useful factsheets for companies and workers.

It includes a new tool that helps businesses and workers to identify carcinogens at work and take preventive measures.

Every year more than 100 000 people in the EU die from cancer that was caused by exposure to carcinogens at work. 

ECHA is a partner of this EU voluntary action scheme that aims to prevent workers from being exposed to carcinogens in the workplace. 

REACH Committee meeting in September 2024

The next meeting of the European Commission’s REACH Committee will take place on 20 September 2024.

European Commission's decisions

Biocides – decisions on active substances and Union authorisations

The Commission has decided not to renew the approval of active substance:

•  sulfuryl fluoride for product-type 8 and 18.

The Commission has granted a Union authorisation for:

• the single biocidal product 'Nordkalk SL 90';
• the single biocidal product 'Nordkalk Filtra G';
• the single biocidal product 'Ca(OH)2 PT02';
• the single biocidal product 'Hydroflex IPA 70 Biocide';
• the single biocidal product 'Ca(OH)2 PT03';
• the single biocidal product 'SANICALCO S';
• the single biocidal product 'Soft Care Med H5';
• the single biocidal product 'EuLA Ca(OH)2';
• the single biocidal product 'Nordkalk SL'; and
• the biocidal product family 'Diversey Hydrogen Peroxide Product Family'.

The Commission has cancelled a Union authorisation for:

• the single biocidal product 'SchwabEX-Guard'.

The Commission has amended a Union authorisation due to administrative and minor changes for:

• the biocidal product family 'Hydrogen Peroxide Family 1'.

Read more about the product-types on our website.

EU Observatory for Nanomaterials (EUON)

Nanopinion: Selenium nanoparticles induce global histone methylation changes in ovarian cancer cells

Read the latest Nanopinion guest column by Professors Steve Conlan and Laurent Charlet. They explore new cancer therapies by leveraging selenium nanoparticles (SeNPs) to modify histone methylation and influence cancer cell behaviour.